ROCO
6523
Market cap125mUSD
Oct 08, Last price
88.90TWD
1D
-0.22%
1Q
-2.31%
Jan 2017
-50.47%
IPO
-54.80%
Name
DR.Wu Skincare Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Dr. Wu Skincare Co., Ltd. is a company that develops and distributes a broad spectrum of skincare and cosmetic products, serving both the Taiwanese domestic market and an international clientele. Their comprehensive product range includes facial cleansers, treatment masks, toners, concentrated serums, various moisturizers (lotions, creams, and gels), UV/DD creams for sun protection, and specialized eye care, alongside general makeup and body care items. Furthermore, the company formulates targeted solutions for specific skin concerns such as acne and pore issues, blackheads, dry skin conditions, visible signs of aging, dull or spotty complexions, sensitive skin, brightening, and emergency skin care. These products are made available through an extensive retail network comprising approximately 2,000 sales locations in diverse regions including Mainland China, Myanmar, Thailand, Malaysia, Singapore, Canada, Vietnam, the Philippines, and Japan. Founded in 2003, Dr. Wu Skincare Co., Ltd. is headquartered in Taipei, Taiwan.
Key people
Yi-Ju Wu
Chairman of the Board, Chief Executive Officer, Acting General Manager · since 2023
Yijun Guo
Deputy General Manager, Director · since 2024
Tiger Hsing
Director · since 2018
Ying-Chin Wu
Director · since 2005
Chao-Sheng Chiang
Independent Director · since 2015
Independent Director · since 2021
Qingyi Li
Independent Director · since 2021
Huangyou Lin
Independent Director · since 2024
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||